ALYSSA BAKER: Open Payments
NPI 1518628460 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 28 payments from 6 companies in 2025. Trend: 2023 $33 · 2024 $0 · 2025 $836
Food & beverage: $764Education: $72
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $224 |
| Neurocrine BioSciences, Inc. | 4 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $186 |
| E.R. Squibb & Sons, L.L.C. | 5 | $103 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
Products named: INGREZZA, CAPLYTA, LYBALVI, ARISTADA, COBENFY, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across MI — which companies pay providers there.
